Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs

NYSE:BMY

Bristol Myers Squibb (BMY)

54.03
+0.03 (0.06%)
as of Jun 18, 2026, 9:49:29 pm Market Open.
111 watching
0
DON'T BUY
Has had a lot of problems. Starting to clear up, but will take awhile.
WEAK BUY
DON'T BUY
Has had problems in manufacturing, shipping and FDA approvals. Exoects slow earnings growth.
BUY
Likes the valuations. Good balance sheet and good earnings.
BUY
Looks cheap. There is an SEC investigation going on.
DON'T BUY
Now is a good time for drug stocks, but this company has corporate problems.
BUY
9.25% dividend. Has been hit hard. Stable cash flow.
TOP PICK
Has been oversold. Very cheap. Could be a takeover.
DON'T BUY
Could drop. Prefers generic drugs.
BUY
Good drug company, but had difficulties getting FDA approvals. Good dividend. Cheap.
BUY
Made some poor moves. Still a triple A company.
PAST TOP PICK
(Was a top pick on May 23. Down 31%). Fell with health care. Price looks very good.
BUY
Trading at 5 X Book. Good dividends. New drug has approval.
BUY
Likes the drug sector. Prefers Pfizer.
DON'T BUY
Doesn't expect much growth, plus there are some issues.
Showing 166 to 180 of 191 entries